ResearcherThe University of Texas Health Science Center at HoustonActive in the last 2 years

Ali Azhdarinia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8000-907X; OpenAlex author ID A5006889389. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics18080920 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Majid Momeny · 1 shared paper, 2026 · strength 0.29
- Paper ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. DOI 10.3390/pharmaceutics18080920 ↗
Urvinder Kaur Sardarni · 1 shared paper, 2026 · strength 0.29
- Paper ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. DOI 10.3390/pharmaceutics18080920 ↗
Vahid Khalaj · 1 shared paper, 2026 · strength 0.29
- Paper ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. DOI 10.3390/pharmaceutics18080920 ↗
MacKenzie V. Demmel · 1 shared paper, 2026 · strength 0.29
- Paper ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. DOI 10.3390/pharmaceutics18080920 ↗
Jennifer M. Bailey · 1 shared paper, 2026 · strength 0.29
- Paper ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. DOI 10.3390/pharmaceutics18080920 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.